Oct 18, 00
|
| 07:50 ET |
Dura Pharmaceuticals Announces Financial Results for the Third Quarter of 2000
|
|
Oct 16, 00
|
| 08:12 ET |
Dura Pharmaceuticals Issued Patent for Methods of Dry Powder Inhalation
|
|
Oct 02, 00
|
| 02:12 ET |
Dura Pharmaceuticals Acquires Exclusive Distribution Rights From Glaxo Wellcome for Dermatology Product Line
|
|
Aug 31, 00
|
| 16:19 ET |
Dura Pharmaceuticals Acquires Spiros Development Corporation II
|
|
Jul 24, 00
|
| 17:11 ET |
Dura Pharmaceuticals Announces a 24% Increase In Year-Over-Year Earnings for the Second Quarter of 2000
|
|
| 17:09 ET |
Dura Pharmaceuticals Refocuses Its Strategy for Future Growth
|
|
Jun 13, 00
|
| 16:15 ET |
Dura Pharmaceuticals to Launch Allergan's Ocuflox(R), A Treatment for Ocular Infections, to Primary Care Physicians
|
|
Apr 18, 00
|
| 08:31 ET |
Dura Pharmaceuticals, Inc. Announces Financial Results For First Quarter of 2000
|
|
Apr 12, 00
|
| 16:30 ET |
Dura Pharmaceuticals Announces Expansion of Pulmonary Drug Delivery Platform Technology
|
|
Apr 06, 00
|
| 16:29 ET |
Dura Pharmaceuticals Launches Alocril(TM), a New Treatment for Itch Associated With Allergic Conjunctivitis, to Primary Care Physicians and Allergists
|
|
Mar 20, 00
|
| 20:12 ET |
Dura Pharmaceuticals Signs Definitive Merger Agreement With Spiros Development Corporation II
|
|
Feb 23, 00
|
| 09:27 ET |
Allergan and Dura Pharmaceuticals Enter Into Segment Alliance Agreement to Promote Multiple Products
|
|
Feb 15, 00
|
| 08:03 ET |
Spiros Development Corporation to Study Offer From Dura Pharmaceuticals
|
|
Feb 14, 00
|
| 07:59 ET |
Dura Pharmaceuticals Offers to Acquire Spiros Development Corporation II
|
|
Jan 24, 00
|
| 16:15 ET |
Dura Pharmaceuticals Reports Fourth Quarter And Full Year 1999 Results
|
|
Jan 05, 00
|
| 07:30 ET |
Dura Pharmaceuticals Appoints F. Richard Nichol to Board of Directors
|
|
Oct 28, 99
|
| 18:15 ET |
Spiros Development Corporation II, Inc. Announces Third Quarter 1999 Results
|
|
Oct 26, 99
|
| 08:33 ET |
Dura Pharmaceuticals and Spiros Development Corporation II Announce Initiation of Clinical Program for Budesonide Spiros
|
|
Oct 14, 99
|
| 07:30 ET |
Dura Pharmaceuticals Reports Third Quarter 1999 Results
|
|
| 07:28 ET |
Dura Pharmaceuticals and Spiros Development Corporation II Announce Initiation of Pivotal Clinical Program for Beclomethasone Spiros
|
|
Oct 04, 99
|
| 16:00 ET |
Dura Pharmaceuticals Settles Scandipharm Litigation
|
|
Jul 29, 99
|
| 17:05 ET |
Spiros Development Corporation II, Inc. Announces Second Quarter 1999 Results
|
|
Jul 15, 99
|
| 08:33 ET |
Dura Pharmaceuticals, Inc. Announces Results For The Second Quarter of 1999
|
|
Apr 26, 99
|
| 07:30 ET |
Spiros Development Corporation II, Inc. Announces First Quarter 1999 Results
|
|
Apr 13, 99
|
| 16:02 ET |
Dura Pharmaceuticals, Inc. Announces Record Revenues for First Quarter of 1999
|
|
Feb 22, 99
|
| 16:05 ET |
Dura Pharmaceuticals and Spiros Development Corporation II Provide Update on Development of Spiros Respiratory Products
|
|
Feb 09, 99
|
| 08:05 ET |
Spiros Development Corporation II, Inc. Reports Fourth Quarter and Full Year 1998 Results
|
|
Jan 28, 99
|
| 17:26 ET |
Dura Pharmaceuticals Announces Filing of Class Action Lawsuit
|
|
Jan 27, 99
|
| 16:05 ET |
Dura Pharmaceuticals Reports Fourth Quarter and Full Year 1998 Results
|
|
Dec 22, 98
|
| 16:02 ET |
Dura Pharmaceuticals Announces Acquisition of Exclusive Distribution Rights for Two Patented Antibiotic Products, Maxipime and Azactam, from Bristol-Myers Squibb
|
|
| 16:02 ET |
Dura Pharmaceuticals Updates Expectations For Fourth Quarter and Year-End 1998 Earnings
|
|
Oct 19, 98
|
| 08:31 ET |
Spiros Development Corporation II, Inc. Reports Third Quarter 1998 Results
|
|
Oct 14, 98
|
| 16:15 ET |
Dura Pharmaceuticals Reports Third Quarter 1998 Results
|
|
Oct 12, 98
|
| 16:38 ET |
Dura Pharmaceuticals, Inc. Announces Stock Repurchase Program
|
|
Sep 23, 98
|
| 15:23 ET |
Lilly And Dura Pharmaceuticals Announce Agreement To Develop Pulmonary Delivery of Insulin
|
|
| 15:07 ET |
Dura Pharmaceuticals and Spiros Development Corp. II Update Development Status of Spiros Asthma Products
|
|
| 15:06 ET |
Dura Pharmaceuticals Announces Lowered Expectations for Second Half 1998 Revenues and Earnings Based on Recent Sales Results
|
|
Jul 29, 98
|
| 08:32 ET |
Dura Pharmaceuticals Announces Co-Promotion Agreement with DJ Pharma
|
|
Jul 21, 98
|
| 08:31 ET |
Spiros Development Corporation II, Inc. Announces Second Quarter 1998 Results
|
|
Jul 14, 98
|
| 07:35 ET |
Dura Pharmaceuticals Announces Acquisition of Myambutol From a Unit of American Home Products
|
|
| 07:30 ET |
Dura Pharmaceuticals Reports Second Quarter 1998 Results
|
|
Jun 24, 98
|
| 08:30 ET |
Dura Pharmaceuticals Strengthens Senior Management Team
|
|
Jun 02, 98
|
| 08:30 ET |
Dura Pharmaceuticals and Spiros Development Corp. II Provide Update on Development of Spiros(R) Asthma Products
|
|
May 22, 98
|
| 16:15 ET |
Dura Pharmaceuticals, Inc. Adopts Shareholder Rights Plan
|
|
Mar 16, 98
|
| 08:04 ET |
Clinical Data on Dura Pharmaceutical's First Investigational Spiros(R) Inhalation Powder Delivery System Presented at AAAAI
|
|
Feb 24, 98
|
| 16:24 ET |
Dura Pharmaceuticals Announces Accelerated Investment in Sales Force Expansion and Lower Than Expected Revenues and Earnings for 1998 Based on Recent Sales Results
|
|